Breast cancer, vaccine

A clinical trial at WashU Medicine shows promising results for a personalized vaccine designed to prevent recurrence in ...
Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with ...
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...
Despite the positive outcome, the seasoned infectious disease researcher, faced multiple challenges when seeking to publish ...
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.
Anixa Biosciences ( (ANIX) ) has provided an announcement. Anixa Biosciences, in collaboration with Cleveland Clinic, unveiled promising ...